Toggle navigation
Home
Search
Services
Blog
Contact
About
Monoclonal Antibody Against 2'-Deoxycytidine, a Putative
Wallace, Thomas
Houston Biotechnology, Inc., The Woodlands, TX, United States
Search 113 grants from Thomas Wallace
Search grants from Houston Biotechnology, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Determinants of voluntary HIV testing among inmates
Vascular Access Clinical Trials Data Coordinating Center
Mechanisms by which troglitazone improves insulin resistance in NIDDM
Development of Standards for the New Ballard Maturation Score
Pilot Study - Semantics of Sentence Accent in Alzheimer's Disease
Recently added grants:
RNA Toxicity and Muscle Regeneration
Epigenetic regulation by tumor suppressor p53
Learning and brain plasticity in children with autism: relation to cognitive inflexibility and restricted-repetitive behaviors
Attentional, temperamental, and physiological process underlying anxiety in preschoolers with ASD
Neural Architecture of Social Emotional Processing and Regulation in Autism Spectrum Disorder: A Dynamic Connectivity Perspective
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43MH010018-001
Application #
2320772
Study Section
Project Start
1991-07-10
Project End
Budget Start
1992-01-09
Budget End
1992-06-09
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Houston Biotechnology, Inc.
Department
Type
DUNS #
City
The Woodlands
State
TX
Country
United States
Zip Code
77381
Related projects
NIH 1992
N43 MH
Monoclonal Antibody Against 2'-Deoxycytidine, a Putative
Wallace, Thomas / Houston Biotechnology, Inc.
NIH 1991
N43 MH
Monoclonal Antibody Against 2'-Deoxycytidine, a Putative
/ Houston Biotechnology, Inc.
Comments
Be the first to comment on Thomas Wallace's grant